How much has PAM2L Biotechnologies raised?

PAM2L Biotechnologies has raised $29.97M in one sourced round on record (Series A), announced October 22, 2026.

Who invested in PAM2L Biotechnologies?

Investors on record for PAM2L Biotechnologies: Business Opportunities for L'Oréal Development, Co-Stone Venture Capital, Fuhua Capital, Guangxin Fund, Tiantu Capital, Woyong Fund, Yael Capital Management Limited and Yunqi Partners. Guangxin Fund led its latest sourced round.

Where is PAM2L Biotechnologies based?

PAM2L Biotechnologies is based in Shenzhen, China.

PAM2L Biotechnologies

PAM2L Biotechnologies is a biomaterial research and development firm that provides synthetic biotechnology and custom application solutions.

Health and bio

Latest funding

$29.97M Series A · October 22, 2026

Led by Guangxin Fund · Source: finance.jrj.com.cn

Funding history ↓

Website: pam2l.com.

Category: Health and bio.

Sectors: Biotechnology, Medical, Pharmaceutical.

Stage: Series A.

Based in: Shenzhen, China.

Last round: Oct 22, 2026 · 1 days ago.

Domain age: 5 years.

On Recent Funding since: Oct 23, 2026.

About PAM2L Biotechnologies

PAM2L Biotechnologies is a company based in Shenzhen, China. Recent Funding lists it under Health and bio. It raised $29.97M in a Series A round in October 2026, led by Guangxin Fund, according to finance.jrj.com.cn. Investors on record include Business Opportunities for L'Oréal Development, Co-Stone Venture Capital, Fuhua Capital, Tiantu Capital and 3 others.

Funding rounds

October 22, 2026
Series A · $29.97M
GGuangxin Fund (lead), BBusiness Opportunities for L'Oréal Development
Source: finance.jrj.com.cn
March 13, 2021
Website created

Investors

Similar Health and bio companies

HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
OOxbridge Health$45M Series B+ · Oct 2026

Questions and sources

PAM2L Biotechnologies: questions and answers

How much has PAM2L Biotechnologies raised?: PAM2L Biotechnologies has raised $29.97M in one sourced round on record (Series A), announced October 22, 2026.
Who invested in PAM2L Biotechnologies?: Investors on record for PAM2L Biotechnologies: Business Opportunities for L'Oréal Development, Co-Stone Venture Capital, Fuhua Capital, Guangxin Fund, Tiantu Capital, Woyong Fund, Yael Capital Management Limited and Yunqi Partners. Guangxin Fund led its latest sourced round.
Where is PAM2L Biotechnologies based?: PAM2L Biotechnologies is based in Shenzhen, China.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/pam2l-biotechnologies (get a free API key).